Median Diagnostics Inc. (XKON:233250)
South Korea · Delayed Price · Currency is KRW 8,500.00
-100.00 (-1.16%)
At close: May 22, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 14.85 billion as of May 22, 2026. Its market cap has decreased by -41.38% in one year.
Market Cap
14.85B
Enterprise Value
n/a
Revenue
7.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,500.00
Market Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 14.85B, a decrease of -32.81%. That is a compound annual growth rate of -4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 14.85B | -25.96% |
| Dec 30, 2025 | 20.05B | -20.83% |
| Dec 30, 2024 | 25.32B | -9.32% |
| Dec 28, 2023 | 27.93B | -44.77% |
| Dec 29, 2022 | 50.56B | -27.35% |
| Dec 30, 2021 | 69.60B | -3.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 323.65B |
| GENINUS | 134.24B |
| GC Medical Science | 124.80B |
| Inventera | 123.96B |
| Cytogen | 110.73B |
| HLB Panagene | 75.75B |
| Protia | 60.72B |
| Seoulin Bioscience | 51.75B |